Allianz Asset Management GmbH Has $45.79 Million Stock Holdings in Amdocs Limited $DOX

Allianz Asset Management GmbH grew its holdings in Amdocs Limited (NASDAQ:DOX) by 13.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 501,809 shares of the technology company’s stock after buying an additional 57,705 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.44% of Amdocs worth $45,785,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Pzena Investment Management LLC increased its stake in shares of Amdocs by 2.1% in the second quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock valued at $597,719,000 after buying an additional 132,463 shares in the last quarter. LSV Asset Management increased its position in Amdocs by 11.1% in the first quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock worth $291,016,000 after purchasing an additional 317,412 shares during the period. Alyeska Investment Group L.P. increased its position in Amdocs by 38.6% in the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after purchasing an additional 648,693 shares during the period. American Century Companies Inc. increased its position in Amdocs by 23.5% in the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after purchasing an additional 426,911 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Amdocs by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,120,075 shares of the technology company’s stock worth $193,978,000 after purchasing an additional 182,489 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Price Performance

Amdocs stock opened at $82.94 on Friday. The firm has a market capitalization of $9.36 billion, a P/E ratio of 16.82, a PEG ratio of 1.37 and a beta of 0.51. Amdocs Limited has a 1 year low of $78.61 and a 1 year high of $95.41. The business has a 50-day moving average of $84.41 and a 200-day moving average of $87.43. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The company had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same period in the previous year, the company earned $1.62 EPS. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. On average, equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, September 30th. Amdocs’s payout ratio is 42.60%.

Analyst Upgrades and Downgrades

DOX has been the subject of a number of research reports. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, October 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Amdocs in a research report on Wednesday, October 8th. Finally, Wolfe Research initiated coverage on Amdocs in a research report on Tuesday, July 8th. They issued an “outperform” rating for the company. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Amdocs has a consensus rating of “Moderate Buy” and an average price target of $108.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.